DongBang Medical
Dongbang Medical Co., Ltd produces and sells medical devices, fillers, bio medical devices, and cosmetics devices in South Korea. It offers HA filler, a medical device used for improving facial wrinkles and volume recovery under the ELASTY GRAND, ELASTY DEEP PLUS, ELASTY G PLUS, ELASTY D PLUS, and ELASTY F PLUS names; threads under the ELASTY LINE, ELASTY MESHFILL, ELASTY-V BARB, ELASTY-V UP, ELA… Read more
Market Cap & Net Worth: DongBang Medical (240550)
DongBang Medical (KQ:240550) has a market capitalization of $45.65K (₩66.84 Million) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #42569 globally and #2377 in its home market, demonstrating a 3.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DongBang Medical's stock price ₩6960.00 by its total outstanding shares 9604 (9.60K).
DongBang Medical Market Cap History: 2025 to 2026
DongBang Medical's market capitalization history from 2025 to 2026. Data shows growth from $51.23K to $45.65K (0.00% CAGR).
DongBang Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DongBang Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 240550 by Market Capitalization
Companies near DongBang Medical in the global market cap rankings as of March 19, 2026.
Key companies related to DongBang Medical by market ranking:
- Heungkuk Fire & Marine Insurance Co. Ltd. Pfd. Series 1 (KQ:000545): Ranked #42560 globally with a market cap of $43.52K USD ( ₩63.73 Million KRW).
- Nunzia Pharmaceutical Corporation (PINK:NUNZ): Ranked #42561 globally with a market cap of $43.45K USD.
- CONTACT ENERGY (BE:BZB): Ranked #42570 globally with a market cap of $43.32K USD ( €42.21K EUR).
- BOLLORE (BOP.SG) (STU:BOP): Ranked #42571 globally with a market cap of $43.32K USD ( €42.20K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42560 | Heungkuk Fire & Marine Insurance Co. Ltd. Pfd. Series 1 | KQ:000545 | $43.52K | ₩7000.00 |
| #42561 | Nunzia Pharmaceutical Corporation | PINK:NUNZ | $43.45K | $0.00 |
| #42570 | CONTACT ENERGY | BE:BZB | $43.32K | €4.56 |
| #42571 | BOLLORE (BOP.SG) | STU:BOP | $43.32K | €4.38 |
DongBang Medical Historical Marketcap From 2025 to 2026
Between 2025 and today, DongBang Medical's market cap moved from $51.23K to $ 45.65K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩45.65K | -10.88% |
| 2025 | ₩51.23K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of DongBang Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.65K USD |
| MoneyControl | $45.65K USD |
| MarketWatch | $45.65K USD |
| marketcap.company | $45.65K USD |
| Reuters | $45.65K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.